Agenda or minutes

UK COVID-19 Therapeutics Advisory Panel: records of decisions

Records of the discussions and decisions in meetings of the UK COVID-19 Therapeutics Advisory Panel (UK-CTAP)

From:
UK-CTAP
Published:

Documents

Details

These are the published records of decisions made by the UK COVID-19 Therapeutics Advisory Panel (UK-CTAP).

UK-CTAP is independent of UK Research and Innovation (UKRI). UKRI has provided secretariat service to the panel throughout its operation.

Some information has been redacted where:

  • the publication of names of pre-approval drugs could impact commercial viability
  • drugs under patent or under development that are submitted by persons who do not own the intellectual property or have commercial interest in the drug.
  • licensed drugs that are still under patent and have commercial interests
  • the information concerns novel formulations of existing drugs
  • the status of the drugs cannot be identified
  • it is protected under the General Data Protection Regulation (GDPR)
  • it is unpublished academic data.

Information has been published where it:

  • is generic with no commercial sensitivity
  • relates to unbranded household foods or substances singularly or in combination
  • is in the public domain either because:
  • it has been recommended for trial
  • the manufacturer has publicly announced their view on efficacy.

This is the integrated website of the 7 research councils, Research England and Innovate UK.
Let us know if you have feedback or would like to help us test new developments.